Aotearoa New Zealand clinicians respond to the 2022 American Heart Association Presidential Advisory Statement regarding penicillin reactions in people with severe rheumatic heart disease

N Z Med J. 2023 Dec 1;136(1586):9-11.
No abstract available

Publication types

  • Editorial

MeSH terms

  • American Heart Association
  • Humans
  • New Zealand
  • Penicillins / adverse effects
  • Rheumatic Fever* / drug therapy
  • Rheumatic Heart Disease*
  • United States

Substances

  • Penicillins